Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
10.52
+1.03 (10.85%)
Apr 29, 2026, 3:04 PM CST
SHE:301060 Revenue
In the year 2025, Shanghai Labway Clinical Laboratory had annual revenue of 1.45B CNY, down -16.88%. Shanghai Labway Clinical Laboratory had revenue of 345.94M in the quarter ending December 31, 2025, a decrease of -18.05%.
Revenue
1.45B
Revenue Growth
-16.88%
P/S Ratio
2.61
Revenue / Employee
1.06M
Employees
1,365
Market Cap
3.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.45B | -294.15M | -16.88% |
| Dec 31, 2024 | 1.74B | 67.81M | 4.05% |
| Dec 31, 2023 | 1.67B | -2.52B | -60.13% |
| Jan 1, 2023 | 4.20B | 2.42B | 136.14% |
| Jan 1, 2022 | 1.78B | 540.14M | 43.62% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guangdong Hybribio Biotech | 691.16M |
| Medicalsystem Biotechnology | 1.47B |
| Berry Genomics Co.,Ltd | 941.16M |
| SMO ClinPlus CO.,LTD. | 819.09M |
| Thalys Medical Technology Group | 1.25B |
| Chemclin Diagnostics | 353.32M |
| Cowealth Medical China | 656.38M |
| Shanghai Rendu Biotechnology | 162.06M |